Menu
Back to User profile » Dr Xiaoji Luo
Papers published by Dr Xiaoji Luo:
Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways [Retraction]
Huang Y, Chen J, Yang S, Tan T, Wang N, Wang Y, Zhang L, Yang C, Huang H, Luo J, Luo X
Drug Design, Development and Therapy 2024, 18:1263-1264
Published Date: 18 April 2024
Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction]
Tan T, Chen J, Hu Y, Wang N, Chen Y, Yu T, Lin D, Yang S, Luo J, Luo X
OncoTargets and Therapy 2023, 16:275-276
Published Date: 12 April 2023
Clinical Outcomes of Fracture Haemorrhage Aspiration for Percutaneous Vertebroplasty in Treating Osteoporotic Vertebral Compression Fractures
Peng J, Qin J, Huang T, Luo X, Zhong W, Quan Z
Journal of Pain Research 2021, 14:3951-3959
Published Date: 31 December 2021
RETRACTED ARTICLE: Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways
Huang Y, Chen J, Yang S, Tan T, Wang N, Wang Y, Zhang L, Yang C, Huang H, Luo J, Luo X
Drug Design, Development and Therapy 2020, 14:4625-4637
Published Date: 30 October 2020
Evodiamine Exerts Anticancer Effects Against 143B and MG63 Cells Through the Wnt/β-Catenin Signaling Pathway
Yang S, Chen J, Tan T, Wang N, Huang Y, Wang Y, Yuan X, Zhang P, Luo J, Luo X
Cancer Management and Research 2020, 12:2875-2888
Published Date: 28 April 2020
RETRACTED ARTICLE: Dihydrotanshinone I inhibits the growth of osteosarcoma through the Wnt/β-catenin signaling pathway
Tan T, Chen J, Hu Y, Wang N, Chen Y, Yu T, Lin D, Yang S, Luo J, Luo X
OncoTargets and Therapy 2019, 12:5111-5122
Published Date: 2 July 2019